Yuyu Pharma, Inc.

₩3,725As of Sun 8 Nov 2026, 12:00 UTC
KRX:000220Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (1.44%)
Div yield 3.09%
ROE 8.85%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.34
PE TTM 5.361
TSR TTM (7.92%)
Mkt cap ₩58.66B
ROIC 8.74%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩4,690
25.91%
(63.01%)
Hold 1|4|1|2|1
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
61.82
66.17
68.04
69.20
11.89%
19.44%
21.69%
18.67%
Revenue₩B
2.935
3.077
3.104
3.022
8.73%
12.32%
7.62%
0.45%
Peers (US$43.25M)
Cap (US$)
PE
49.92M
13.31x
46.63M
2.890x
Capital
TTM
5Y
10Y
Leveragex
2.383
1.083
0.869
EBIT/Intx
0.196
0.469
0.475
Own earn%
(65.05)
18.57
18.01
Sh yield%
23.80
22.55
22.45
Owners
Insiders/Inst%
12.37
22.32
Short interest%
5.22
SBC / revenue%
1.67
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
7–12
$1 testx
0.0
Incr. ROIC%
8